BTC 
ETH 
BNB 
XRP 
SOL 
TRX Haemonetics shares reach highs after FDA approval ahead of earnings
Investor's Business Daily reported that Haemonetics, a provider of blood products management tools, hit highs following an FDA approval as earnings loom. The post describes the company's plasma collection and blood collection systems, training and services. No approval details, figures or dates are given.
Why “Unverified”
- Reported by Investor's Business Daily alone, with no second source or primary confirmation yet
1 independent source group across 1 post · evidence score 52/100. How labels work
What the sources claim
-
Haemonetics shares reached highs after an FDA approval, with earnings upcoming.
“Blood Plasma Name Hits Highs On FDA Approval As Earnings Loom”
Investor's Business Daily -
Haemonetics provides tools for blood products management, including plasma collection and blood collection systems, training and services.
“Haemonetics provides tools for blood products management such as plasma collection and providing systems, training and services for blood collection.”
Investor's Business Daily
Sources
More in Stocks & Indices
Summary and claims extracted by AI with prompt analyze-story@5 on 2026-10-28 17:20 UTC. Labels are computed from the sources, not by the model.